3 ms·
>If Big Pharma wanted to push dangerous or ineffective drugs on the public, there are far easier and cheaper ways to go about it than coming up with elaborate d
by SilasX 14y ago
>If Big Pharma wanted to push dangerous or ineffective drugs on the public, there are far easier and cheaper ways to go about it than coming up with elaborate double-blind, randomized, placebo-controlled testing protocols. See: Vioxx.
??? Vioxx was not at all cheap or easy to bring to market, nor was it ineffective. Rather, it was a case where a drug was tremendously beneficial to most users but deadly for a small subset. Even after its withdrawal from the market, US and Canadian government panels have voted in favor of bringing it back based on cost-benefit analysis!
http://en.wikipedia.org/wiki/Vioxx#Withdrawal http://en.wikipedia.org/wiki/Vioxx#Withdrawal
I don't think it's possible to have a worse example of the drug company behavior you mentioned. Why not point to the days of phony, deadly cures being pushed on a naive population? Vioxx had actual research and efficacy behind it, and may actually merit coming back on the market.
- bitwize 14y agoMerck had a sweetheart deal with Elsevier to publish a vanity journal which passed off marketing copy for Vioxx as "research". Why not point to the days of phony, deadly cures being pushed on a naive population? That's still going on, except these days the pushers of phony, deadly cures sound a lot like Alex3917. Hint: look for accusations of medical researchers being "shills of big pharma". Vioxx gives us a handy, recent example of big pharma actually behaving badly,and they had to undermine science to do it. Just like the peddlers of unproven "alternative cures" -- and quite unlike, and to the dismay of, the medical research community.
- SilasX 14y agoIf it's being recommended for re-introduction even knowing what actually happened, and is responsible for the health of the overwhelming majority of those who took it, I don't think that counts as an example of a case where you "needed" to corrupt journals to get it approved.